In vitro inhibition of human herpesvirus-6 by phosphonoformate. 1988

H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
National Cancer Institute, Bethesda, Maryland 20892.

HSB-2 cell cultures productively infected with human herpesvirus-6 were treated with the antiviral drugs phosphonoformic acid (PFA), acyclovir (ACV), and gancyclovir (DHPG). ACV and DHPG showed significant toxic effects on uninfected HSB-2 cells, yet only incompletely inhibited viral expression upon infection of the cells. PFA, however, showed little direct toxicity on HSB-2 cells while viral replication was inhibited significantly.

UI MeSH Term Description Entries
D009943 Organophosphorus Compounds Organic compounds that contain phosphorus as an integral part of the molecule. Included under this heading is broad array of synthetic compounds that are used as PESTICIDES and DRUGS. Organophosphorus Compound,Organopyrophosphorus Compound,Organopyrophosphorus Compounds,Compound, Organophosphorus,Compound, Organopyrophosphorus,Compounds, Organophosphorus,Compounds, Organopyrophosphorus
D010746 Phosphonoacetic Acid A simple organophosphorus compound that inhibits DNA polymerase, especially in viruses and is used as an antiviral agent. Phosphonoacetate,Disodium Phosphonoacetate,Fosfonet Sodium,Phosphonacetic Acid,Phosphonoacetate, Disodium
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006564 Herpesviridae A family of enveloped, linear, double-stranded DNA viruses infecting a wide variety of animals. Subfamilies, based on biological characteristics, include: ALPHAHERPESVIRINAE; BETAHERPESVIRINAE; and GAMMAHERPESVIRINAE. Mouse Thymic Virus,Murid herpesvirus 3,Thymic Group Viruses,Herpesviruses,Mouse Thymic Viruses,Thymic Virus, Mouse,Thymic Viruses, Mouse
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000212 Acyclovir A GUANOSINE analog that acts as an antimetabolite. Viruses are especially susceptible. Used especially against herpes. Acycloguanosine,9-((2-Hydroxyethoxy)methyl)guanine,Aci-Sanorania,Acic,Aciclobeta,Aciclostad,Aciclovir,Aciclovir Alonga,Aciclovir-Sanorania,Acifur,Acipen Solutab,Acivir,Activir,Acyclo-V,Acyclovir Sodium,Antiherpes Creme,Avirax,Cicloferon,Clonorax,Cusiviral,Genvir,Herpetad,Herpofug,Herpotern,Herpoviric,Isavir,Laciken,Mapox,Maynar,Milavir,Opthavir,Supraviran,Viclovir,Vipral,Virax-Puren,Virherpes,Virmen,Virolex,Virupos,Virzin,Wellcome-248U,Zoliparin,Zovirax,Zyclir,aciclovir von ct,Aci Sanorania,Aciclovir Sanorania,Acyclo V,Alonga, Aciclovir,Sodium, Acyclovir,Solutab, Acipen,Virax Puren,ViraxPuren,Wellcome 248U,Wellcome248U
D000998 Antiviral Agents Agents used in the prophylaxis or therapy of VIRUS DISEASES. Some of the ways they may act include preventing viral replication by inhibiting viral DNA polymerase; binding to specific cell-surface receptors and inhibiting viral penetration or uncoating; inhibiting viral protein synthesis; or blocking late stages of virus assembly. Antiviral,Antiviral Agent,Antiviral Drug,Antivirals,Antiviral Drugs,Agent, Antiviral,Agents, Antiviral,Drug, Antiviral,Drugs, Antiviral
D015774 Ganciclovir An ACYCLOVIR analog that is a potent inhibitor of the Herpesvirus family including cytomegalovirus. Ganciclovir is used to treat complications from AIDS-associated cytomegalovirus infections. BIOLF-62,BW-759,Cytovene,Ganciclovir Sodium,Ganciclovir, Monosodium Salt,Gancyclovir,RS-21592
D017245 Foscarnet An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV. Phosphonoformate,Phosphonoformic Acid,Foscarnet Barium (2:3) Salt,Foscarnet Calcium (2:3) Salt,Foscarnet Disodium Salt,Foscarnet Magnesium (2:3) Salt,Foscarnet Manganese (2+) (2:3) Salt,Foscarnet Sodium,Foscarnet Sodium Hexahydrate,Foscarnet Trilithium Salt,Foscarnet Tripotassium Salt,Foscarnet Trisodium Salt,Foscavir,Trisodium Phosphonoformate

Related Publications

H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
January 1980, Archives of virology,
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
February 1978, Antimicrobial agents and chemotherapy,
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
April 2004, Stem cells and development,
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
June 1985, Lancet (London, England),
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
June 2011, Pharmaceutical biology,
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
April 1985, Antimicrobial agents and chemotherapy,
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
January 1994, In vivo (Athens, Greece),
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
December 1980, Virology,
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
September 1990, The Journal of infectious diseases,
H Z Streicher, and C L Hung, and D V Ablashi, and K Hellman, and C Saxinger, and J Fullen, and S Z Salahuddin
January 1980, Intervirology,
Copied contents to your clipboard!